Silencing HKII did not significantly change the treatment response to either 2-DG (Figure 5(c)) or MP (Figure 5(d)), implying that the cytotoxic effect of 2-DG in this ch-ALL cell line is not dependent on its ability to inhibit glycolysis. The gene discussed is HK2; the disease is acute lymphoblastic leukemia.